(Q51651054)

English

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

scientific article published in October 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

0 references

American Thoracic Society

1

object named as

American Thoracic Society

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

European Respiratory Society

2

object named as

European Respiratory Society

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

168

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

7

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

818-900

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neonatal screening for alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Human plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Repair of elastase-digested elastic fibers in acellular matrices by replating with neonatal rat-lung lipid interstitial fibroblasts or other elastogenic cell types

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Smoking, lung function, and alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Demographic and anthropometric correlates of maximum inspiratory pressure: The Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pulmonary rehabilitation in patients with COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The emphysemas: radiologic-pathologic correlations

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pathophysiology of the Pulmonary Circulation in Emphysema Associated with Alpha 1 Antitrypsin Deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Assessment of the progression of emphysema by quantitative analysis of spirometrically gated computed tomography images.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Assessment of lung volumes using helical CT at inspiration and expiration: comparison with pulmonary function tests

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

CT lung densitometry in assessing intralobular air content. An experimental and clinical study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Measurement of pulmonary parenchymal attenuation: use of spirometric gating with quantitative CT.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The effects of age, sex, lung size, and hyperinflation on CT lung densitometry

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Development and application of assays for elastase-specific fibrinogen fragments

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Surrogate end points in clinical trials: are we being misled?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Bronchiectasis and homozygous (P1ZZ) alpha 1-antitrypsin deficiency in a young man.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-Antitrypsin Deficiency-Associated Panniculitis: Case Report and Review of the Literature

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Obstructive Lung Disease in Heterozygotes for Alpha-1 Antitrypsin Deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pi-Z Phenotypes in a Pulmonary Clinic: Their Prevalence and Physiologic State

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Obstructive airway disease associated with heterozygous alpha-1 antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Relation of Protease Inhibitor Phenotypes to Obstructive Lung Diseases in a Community

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Is a low serum concentration of alpha 1-antitrypsin associated with an increased susceptibility for byssinosis in cotton mill workers? Considerations regarding analytical quality requirements and economical consequences.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-Antitrypsin Types and Pulmonary Disease among Employees at a Sulphite Pulp Factory in Northern Sweden

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1 antitrypsin in childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Erythromycin and diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Medium term functional results of single-lung transplantation for endstage obstructive lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Lung function after bilateral lower lobe lung volume reduction surgery for alpha1-antitrypsin emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pregnancy and alpha-1 antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Oxygen supplementation during air travel in patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A Multivariate Analysis of the Risk of Pulmonary Complications After Laparotomy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Gene repair using chimeric RNA/DNA oligonucleotides

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin deficiency--a model for conformational diseases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1-antitrypsin screening of 18-year-old men

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Familial prevalence of chronic obstructive pulmonary disease in a matched pair study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic-environmental interactions in chronic airways obstruction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Histopathology of α1-antitrypsin liver disease in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-antitrypsin bodies in the liver

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neonatal hepatitis syndrome and alpha-1-antitrypsin deficiency: an epidemiological study in South-East England

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Long term prognosis for babies with neonatal liver disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Prognosis of babies with neonatal hepatitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Extrahepatic biliary atresia versus neonatal hepatitis. Review of 137 prospectively investigated infants

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Long-term prognosis for infants with intrahepatic cholestasis and patent extrahepatic biliary tract

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin deficiency with cirrhosis associated with the protease inhibitor phenotype SZ

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Liver disease in adults with alpha-1 -antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Liver Function in Asymptomatic Adult Individuals with Severe α1-Antitrypsin Deficiency (Pi Z)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Serine protease inhibitors in patients with chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Occurrence of Alpha-1-antitrypsin Deficiency in 155 Patients with Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Prognosis and life expectancy on alpha-1-antitrypsin deficiency and chronic liver disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Liver carcinoma in PiZ alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-antitrypsin Pi S phenotype and liver cell inclusion bodies in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-antitrypsin deficiency in Southern African hepatocellular carcinoma patients: An immunoperoxidase and histochemical study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Hepatocytic globules in end-stage hepatic disease: relationship to alpha1-antitrypsin phenotype

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The fetal liver in PiZZ alpha-1-antitrypsin deficiency: a report of five cases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Conformational disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin deficiency, emphysema, necrotizing angiitis and glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Severe hypertension after liver transplantation in alpha 1 antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Changes in aortic wall stiffness in men with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Risk factors for multiple intracranial aneurysms.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin deficiency with severe panniculitis. Report of two cases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Management of urticaria and angioedema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Chronic pancreatitis and alpha-1-antitrypsin

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha1-antitrypsin genotypes in patients with chronic pancreatitis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Alpha-1-antitrypsin, autism, and coeliac disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

alpha 1-Antitrypsin and coeliac disease in spain

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neonatal alpha1-antitrypsin screening: parents' views and reactions 20 years after the identification of the deficiency state

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological consequences of neonatal screening for alpha 1 antitrypsin deficiency (ATD). Parental attitudes toward "ATD-check-ups" and parental recommendations regarding future screening

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychosocial effects of screening for somatic risk: the Swedish alpha 1 antitrypsin experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological consequences of neonatal screening for alpha 1-antitrypsin deficiency. Parental reactions to the first news of their infants' deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Identifying children at high somatic risk: possible effects on the parents' views of the child's health and parents' relationship to the pediatric health services

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Identifying children at high somatic risk: long-term effects on mother-child interaction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Neonatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Reduced morbidity in patients with cystic fibrosis detected by neonatal screening

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Clinical outcomes of newborn screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Molecular confirmation of alpha 1-antitrypsin genotypes in newborn dried blood specimens

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Three cases of alpha-1-antitrypsin deficiency in the elderly

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Mammography adherence and psychological distress among women at risk for breast cancer.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological and behavioral implications of abnormal mammograms.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A descriptive study of BRCA1 testing and reactions to disclosure of test results

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Self-selection in predictive testing for Huntington's disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic testing for cancer in children. Short-term psychological effect.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Familial hypercholesterolaemia: a pilot study of parents' and children's concerns.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological costs and benefits of predictive testing for Huntington's disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic testing of children

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Parents' responses to predictive genetic testing in their children: report of a single case study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Identifying children at high somatic risk: possible long-term effects on the parents' views of their own health and current life situation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Identifying children at high somatic risk: possible long-term effects on the parents' attitudes and feelings associated with the child

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Effects of newborn screening of cystic fibrosis on reported maternal behaviour

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic discrimination in the workplace

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic discrimination: perspectives of consumers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Laws restricting health insurers' use of genetic information: impact on genetic discrimination

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The direct medical costs of alpha(1)-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic testing and informed consent

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The autonomy paradox: predictive genetic testing and autonomy: three essential problems.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic screening and haemoglobinopathies: ethics, politics and practice.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Psychological factors in cost-benefit analysis of somatic prevention. A study of the psychological effects of neonatal screening for alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

The evolving duty to disclose the presence of genetic disease to relatives

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Activity of α1-antitrypsin and cigarette smoking in subarachnoid haemorrhage from ruptured aneurysm

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Can CT Measurement of Emphysema Severity Aid Patient Selection for Lung Volume Reduction Surgery?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

A Kinetic Mechanism for the Polymerization of α1-Antitrypsin

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

CT Measurements of Lung Density in Life Can Quantitate Distal Airspace Enlargement—An Essential Defining Feature of Human Emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

alpha1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.168.7.818

21 January 2018

Identifiers

10.1164/RCCM.168.7.818

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

release_7i4byfymvrdtdnl4t6jhewiusm

1 reference

https://api.fatcat.wiki/v0/release/7i4byfymvrdtdnl4t6jhewiusm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/14522813

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51651054&oldid=2070095083"